Xencor (XNCR) EBT Margin Growth (1y) (2014 - 2026)
Xencor (XNCR) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -270,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -270,099.00 |
| Dec 31, 2025 | 6,934.00 |
| Sep 30, 2025 | 23,789.00 |
| Jun 30, 2025 | 21,645.00 |
| Mar 31, 2025 | 31,586.00 |
| Dec 31, 2024 | -5,966.00 |
| Sep 30, 2024 | -22,559.00 |
| Jun 30, 2024 | -13,142.00 |
| Mar 31, 2024 | -15,505.00 |
| Dec 31, 2023 | 3,285.00 |
| Sep 30, 2023 | 7,502.00 |
| Jun 30, 2023 | 4,434.00 |
| Mar 31, 2023 | -33,841.00 |
| Dec 31, 2022 | -10,508.00 |
| Sep 30, 2022 | 8,818.00 |
| Jun 30, 2022 | -11,714.00 |
| Mar 31, 2022 | 7,772.00 |
| Dec 31, 2021 | 8,015.00 |
| Sep 30, 2021 | -16,874.00 |
| Jun 30, 2021 | 18,406.00 |